Mirae Asset Global Investments Co., Ltd. Atea Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $24 Billion
- Q4 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,815 shares of AVIR stock, worth $8,698. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,815
Previous 3,053
7.8%
Holding current value
$8,698
Previous $10,000
10.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding AVIR
# of Institutions
112Shares Held
50.9MCall Options Held
7.6KPut Options Held
38.7K-
Black Rock Inc. New York, NY9.12MShares$28.2 Million0.0% of portfolio
-
Bml Capital Management, LLC Zionsville, IN7.61MShares$23.5 Million15.83% of portfolio
-
Tang Capital Management LLC San Diego, CA4.79MShares$14.8 Million1.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.67MShares$14.4 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.34MShares$10.3 Million0.52% of portfolio
About Atea Pharmaceuticals, Inc.
- Ticker AVIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,258,600
- Market Cap $257M
- Description
- Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...